Loading…
Algenex is a European biotech company that develops disruptive technologies for recombinant biologics production using proprietary Baculovirus vector expression systems in insect cells. Its two patented platforms, Top Bac® and CrisBio®, aim to address industry challenges in development time, scalability, versatility, and cost for protein production across animal health, human health, and diagnostics.
AI named Algenex from February 2026 to March 2026.